Vera Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 1,127 | -564 | -563 | |
EBITDA | -85,337 | -77,769 | -74,094 | -49,817 |
EBIT | -85,472 | -78,333 | -74,657 | -49,902 |
Net Income | -91,097 | -80,293 | -76,531 | -51,694 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -70,096 | -62,039 | -55,006 | -54,593 |
Cash | 354,725 | 57,773 | 49,121 | 55,090 |
Basic Shares | 64,233 | 63,847 | 63,789 | 63,671 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,862 | $0 |
Gross Profit | -468 | -2,169 | 1,862 | 846 |
EBITDA | -291,617 | -144,416 | -92,182 | -91,749 |
EBIT | -292,085 | -144,521 | -92,203 | -90,903 |
Net Income | -299,615 | -152,148 | -95,990 | -89,056 |
Net Change In Cash | 0 | 0 | 1,862 | 0 |
Cost of Revenue | -36,215 | |||
Free Cash Flow | -241,734 | -135,651 | -92,244 | -67,658 |
Cash | 354,725 | 92,646 | 45,681 | 43,459 |
Basic Shares | 64,233 | 55,326 | 42,707 | 26,570 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$1.39 |
2025-09-30 | -$1.26 |
2025-06-30 | -$1.20 |
